Sauchinone further reduced hepatic steatosis by modulating lipid metabolism PPAR signaling pathway, downregulating liver subtilisin/kexin type 9 expression, activating liver low density lipoprotein LDL receptor expression, and increasing LDL-cholesterol uptake in obese mice (Chae et al., 2018). Here, PPARA is linked to fatty liver disease.